ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag european medicines agency culture microbiology

Updated Sept 1
coronavirus pandemic news articles covid-19 sars-cov-2 virology research science
Follow the Coronavirus Outbreak
The Scientist | Feb 20, 2020 | 10+ min read
Saliva tests screen staff and students at University of Illinois; Study ranks species most susceptible to SARS-CoV-2 infection; COVID-19 clinical trials test drugs that inhibit kinin system
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Viral Soldiers
Jyoti Madhusoodanan | Jan 1, 2016 | 10+ min read
Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.
Going Viral
Breeann Kirby and Jeremy J. Barr | Sep 1, 2013 | 10+ min read
From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.
How to Create a Successful Fish Tale?
A. J. S. Rayl | Aug 19, 2001 | 10+ min read
More than 80 percent of the planet's living organisms exist only in aquatic ecosystems. Some may harbor secrets to human origins, and clues, treatments--perhaps even cures--for human disease. Some are critical bioindicators that portend the health of the biosphere. Yet, overall, scientists know little about the biochemical processes of these life forms. The vast, rich knowledge within the oceans and freshwater systems on Earth remains virtually untapped, because in the world of biological resear
World Bank And Its New Adviser On Human Development Strive To Improve The Health Of Impoverished Populations
Steve Sternberg | Feb 4, 1996 | 8 min read
Strive To Improve The Health Of Impoverished Populations Author: Steve Sternberg The World Bank, once a stronghold of public-spirited but nonscientific economists, has over the past decade emerged as the major financier of research to improve the health of people in Third World countries. Banking on Health: Richard G.A. Feachem, World Bank senior adviser on human development, has put health at the top of the bank's agenda. Each year, the World Bank invests $2 billion for health programs in i
Deliberating Over Danger
The Scientist | Apr 1, 2012 | 10+ min read
The creation of H5N1 bird flu strains that are transmissible between mammals has thrown the scientific community into a heated debate about whether such research should be allowed and how it should be regulated.
Legions Of Life Scientists Will Be Called To The Front, As War On AIDS Intensifies
Ricki Lewis | Jun 27, 1993 | 9 min read
With the pandemic mounting and no sure remedies in sight, experts foresee the growing recruitment of skilled researchers On May 21, the World Health Organization announced that 14 million people have been infected with HIV so far, and the global figure could hit 40 million by the year 2000. And the ninth international AIDS meeting in Berlin earlier this month yielded little startling information beyond the general agreement among scientists that they have been, in effect, stymied thus f
John Maddox Offers Surprising Insights Into His
Bernard Dixon | Jun 12, 1988 | 8 min read
In 1955, a puckish, 30-year-old Weishman resigned as lecturer in theoretical physics at the University of Manchester to become science correspondent of the Manchester Guardian. Unwittingly, the energetically eclectic John Maddox thus took his first step toward the editorial chair of Nature, which he has occupied with distinction on two occasions—between 1966 and 1973, and from 1980 until the present. A robust defender of what he calls “the scientific enterprise,” Maddox has

Run a Search

ADVERTISEMENT